BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21541354)

  • 1. Regulation of cancer aggressive features in melanoma cells by microRNAs.
    Greenberg E; Hershkovitz L; Itzhaki O; Hajdu S; Nemlich Y; Ortenberg R; Gefen N; Edry L; Modai S; Keisari Y; Besser MJ; Schachter J; Shomron N; Markel G
    PLoS One; 2011 Apr; 6(4):e18936. PubMed ID: 21541354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.
    De Tomi E; Campagnari R; Orlandi E; Cardile A; Zanrè V; Menegazzi M; Gomez-Lira M; Gotte G
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
    Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
    Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
    Wu J; Li J; Ren J; Zhang D
    Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
    Mazar J; DeYoung K; Khaitan D; Meister E; Almodovar A; Goydos J; Ray A; Perera RJ
    PLoS One; 2010 Nov; 5(11):e13779. PubMed ID: 21072171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
    BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
    Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.
    Pang RT; Leung CO; Lee CL; Lam KK; Ye TM; Chiu PC; Yeung WS
    BMC Cancer; 2013 Jan; 13():25. PubMed ID: 23327670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
    Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
    J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
    Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
    Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
    J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
    Long J; Luo J; Yin X
    Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
    Zehavi L; Avraham R; Barzilai A; Bar-Ilan D; Navon R; Sidi Y; Avni D; Leibowitz-Amit R
    Mol Cancer; 2012 Jul; 11():44. PubMed ID: 22747855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.